Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30
United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
125,000
$0.04
$5.00K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
37,500
$0.28
$10.50K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
50,000
$0.28
$14.00K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
25,000
$0.46
$11.50K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
20,000
$0.54
$10.80K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
90,380
$1.03
$93.09K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
9,620
$1.03
$9.91K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
1,542
$1.61
$2.48K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
98,458
$1.61
$158.52K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
43,750
$2.84
$124.25K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
48,801
$4.13
$201.55K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
1,199
$4.13
$4.95K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
34,612
$6.37
$220.48K
Vlad Coric
3 Oct 2022
Chief Executive Officer
Exercised, kept
387
$6.37
$2.47K
Gregory Bailey
3 Oct 2022
Director
Exercised, kept
9,000
$3.06
$27.54K
Gregory Bailey
3 Oct 2022
Director
Exercised, kept
9,000
$2.33
$20.97K
Gregory Bailey
3 Oct 2022
Director
Exercised, kept
5,998
$3.56
$21.35K
Gregory Bailey
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K
Matthew Buten
3 Oct 2022
Chief Financial Officer
Exercised, kept
11,450
$6.37
$72.94K
Matthew Buten
3 Oct 2022
Chief Financial Officer
Exercised, kept
1,550
$6.37
$9.87K
Robert J Hugin
3 Oct 2022
Director
Exercised, kept
9,474
$3.39
$32.12K
Robert J Hugin
3 Oct 2022
Director
Exercised, kept
5,998
$3.56
$21.35K
Robert J Hugin
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K
John W Childs
3 Oct 2022
Director
Exercised, kept
5,998
$3.56
$21.35K
John W Childs
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K
Julia P Gregory
3 Oct 2022
Director
Exercised, kept
9,000
$3.06
$27.54K
Julia P Gregory
3 Oct 2022
Director
Exercised, kept
9,000
$2.33
$20.97K
Julia P Gregory
3 Oct 2022
Director
Exercised, kept
5,998
$3.56
$21.35K
Julia P Gregory
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K
Kishan Mehta
3 Oct 2022
Director
Exercised, kept
10,000
$1.86
$18.60K
Kishan Mehta
3 Oct 2022
Director
Exercised, kept
7,500
$2.58
$19.35K
Kishan Mehta
3 Oct 2022
Director
Exercised, kept
6,502
$4.61
$29.97K
Kishan Mehta
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
12,500
$0.54
$6.75K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
4,500
$1.86
$8.37K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
20,716
$1.03
$21.34K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
295
$1.03
$303.85
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
1,542
$1.61
$2.48K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
30,958
$1.61
$49.84K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
3,000
$2.52
$7.56K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
14,000
$2.84
$39.76K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
13,801
$4.13
$57.00K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
1,199
$4.13
$4.95K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
12,612
$6.37
$80.34K
Kimberly Gentile
3 Oct 2022
SVP, Clinical Operations
Exercised, kept
387
$6.37
$2.47K
Michael Thomas Heffernan
3 Oct 2022
Director
Exercised, kept
13,100
$2.40
$31.44K
Michael Thomas Heffernan
3 Oct 2022
Director
Exercised, kept
5,998
$3.56
$21.35K
Michael Thomas Heffernan
3 Oct 2022
Director
Exercised, kept
4,119
$4.84
$19.94K

What was left out

Form 4 filings counted 107
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 76,404,592
History held since 5 Oct 2022